CIK 0001124524 · Accelerated filer
Cryoport, Inc.
Sign in to watch- Ticker
- CYRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 880313393
- Phone
- (949) 232-1900
- Business address
- 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
- Former names
- CRYOPORT SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,702,237
- in 2 filings, $1.5M under 10b5-1 plans
Net −$1,702,237. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-14 | Sawicki Mark W Chief Scientific Officer | Grant or award | +9,000 | 87,528 | ||
| 2025-03-14 | Sawicki Mark W Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2025-03-14 | SHELTON JERRELL President, CEO | Grant or award | +30,000 | 770,019 | ||
| 2025-03-14 | SHELTON JERRELL President, CEO | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-03-10 | Sawicki Mark W Chief Scientific Officer | Sale | −1,583 | $4.88 | $8K | 78,528 |
| 2025-03-10 | SHELTON JERRELL President, CEO | Sale | −4,173 | $4.88 | $20K | 740,019 |
| 2025-03-10 | STEFANOVICH ROBERT Chief Financial Officer | Sale | −1,256 | $4.88 | $6K | 183,078 |
| 2025-03-09 | Sawicki Mark W Chief Scientific Officer | Option exercise | +2,667 | 80,111 | ||
| 2025-03-09 | Sawicki Mark W Chief Scientific Officer | Option exercise · Restricted Stock Rights | −2,667 | 0 | ||
| 2025-03-09 | SHELTON JERRELL President, CEO | Option exercise | +8,250 | 744,192 | ||
| 2025-03-09 | SHELTON JERRELL President, CEO | Option exercise · Restricted Stock Rights | −8,250 | 0 | ||
| 2025-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | +2,667 | 184,334 | ||
| 2025-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise · Restricted Stock Rights | −2,667 | 0 | ||
| 2024-12-11 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | +53,334 | $4.80 | $256K | 181,667 |
| 2024-12-11 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise · Options to purchase common stock | −53,334 | 0 | ||
| 2024-12-02 | Mandalam Ramkumar Director | Option exercise 10b5-1 | +10,834 | $4.80 | $52K | 66,866 |
| 2024-12-02 | Mandalam Ramkumar Director | Sale 10b5-1 | −7,369 | $7.46 | $55K | 59,497 |
| 2024-12-02 | Mandalam Ramkumar Director | Option exercise · Stock Option (right to buy) 10b5-1 | −10,834 | 0 | ||
| 2024-11-22 | SHELTON JERRELL President, CEO | Option exercise 10b5-1 | +26,862 | $4.80 | $129K | 758,759 |
| 2024-11-22 | SHELTON JERRELL President, CEO | Sale 10b5-1 | −22,817 | $6.47 | $148K | 735,942 |
Page 7 of 13 · 254 trades